CD8A and neoplasm: Additionally, targeting phosphoglycerate mutase 1 (PGAM1) has shown promise in promoting ferroptosis and enhancing CD8 + T cell infiltration, which, when combined with ICIs, could amplify anti-tumor effects [72].